Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–7 of 7 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Completed
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
NCT02844816
- Conditions
- Recurrent Bladder Urothelial Carcinoma, Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7, Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7, +1 more
- Locations
-
- Southern Cancer Center PC-Daphne Daphne, Alabama, United States
- Southern Cancer Center PC-Mobile Mobile, Alabama, United States
- Southern Cancer Center PC-Providence Mobile, Alabama, United States
- Southern Cancer Center PC-Springhill Mobile, Alabama, United States
NCT03513952
- Conditions
- Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Carcinoma, +40 more
- Locations
-
- Kaiser Permanente-Riverside Riverside, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Straub Clinic and Hospital Honolulu, Hawaii, United States
- University of Hawaii Cancer Center Honolulu, Hawaii, United States
NCT04496219
- Conditions
- Bladder Urothelial Carcinoma in Situ, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer
NCT00749892
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +32 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer
NCT03237780
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Locally Advanced Bladder Urothelial Carcinoma, +36 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Keck Medicine of USC Buena Park Buena Park, California, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- City of Hope at Irvine Lennar Irvine, California, United States
Active, Not Recruiting
Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy
NCT04963153
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +36 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
- Moffitt Cancer Center Tampa, Florida, United States
Active, Not Recruiting
ARID1A and/or KDM6A Mutation and CXCL13 Expression
NCT04953104
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +48 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States